Title 42, The Public Health and WelfareRelease 119-110

§285l–4 Federal Agency Action

Title 42 › CHAPTER 6A — PUBLIC HEALTH SERVICE › SUBCHAPTER III — NATIONAL RESEARCH INSTITUTES › Part C — Specific Provisions Respecting National Research Institutes › subpart 12 — national institute of environmental health sciences › § 285l–4

Last updated Sep 22, 2026|Official source

Summary

Federal agencies that require or recommend animal acute or chronic toxicity tests must take action after ICCVAM makes a test recommendation. Within 180 days of getting the recommendation, an agency must find and send ICCVAM any rules or industry guidelines that call for animal acute or chronic tests that the ICCVAM method could replace or add to. In that same 180-day period the agency must review the ICCVAM recommendation and tell ICCVAM in writing what it decides. The agency must adopt the ICCVAM recommendation unless it finds the recommendation is not biologically relevant, does not produce the same amount and scientific quality of data for hazard identification, dose‑response, or risk assessment, does not apply to that chemical class or endpoint, or does not meet the agency’s specific testing needs or congressional mandate. Agencies must also promote and encourage development and use of alternative test methods when those alternatives give data at least equal in amount and scientific value for the needed assessments. Before any new or changed acute or chronic test method—animal or alternative—can be required, recommended, or encouraged, the agency must make sure it is validated for its intended use.

Full Legal Text

Title 42, §285l–4

The Public Health and Welfare, Source: USLM XML via OLRC

(a)Identification of tests
With respect to each Federal agency carrying out a program that requires or recommends acute or chronic toxicological testing, such agency shall, not later than 180 days after receiving an ICCVAM test recommendation, identify and forward to the ICCVAM any relevant test method specified in a regulation or industry-wide guideline which specifically, or in practice requires, recommends, or encourages the use of an animal acute or chronic toxicological test method for which the ICCVAM test recommendation may be added or substituted.
(b)Alternatives
Each Federal agency carrying out a program described in subsection (a) shall promote and encourage the development and use of alternatives to animal test methods (including batteries of tests and test screens), where appropriate, for the purpose of complying with Federal statutes, regulations, guidelines, or recommendations (in each instance, and for each chemical class) if such test methods are found to be effective for generating data, in an amount and of a scientific value that is at least equivalent to the data generated from existing tests, for hazard identification, dose-response assessment, or risk assessment purposes.
(c)Test method validation
Each Federal agency carrying out a program described in subsection (a) shall ensure that any new or revised acute or chronic toxicity test method, including animal test methods and alternatives, is determined to be valid for its proposed use prior to requiring, recommending, or encouraging the application of such test method.
(d)Review
Not later than 180 days after receipt of an ICCVAM test recommendation, a Federal agency carrying out a program described in subsection (a) shall review such recommendation and notify the ICCVAM in writing of its findings.
(e)Recommendation adoption
Each Federal agency carrying out a program described in subsection (a), or its specific regulatory unit or units, shall adopt the ICCVAM test recommendation unless such Federal agency determines that—
(1)the ICCVAM test recommendation is not adequate in terms of biological relevance for the regulatory goal authorized by that agency, or mandated by Congress;
(2)the ICCVAM test recommendation does not generate data, in an amount and of a scientific value that is at least equivalent to the data generated prior to such recommendation, for the appropriate hazard identification, dose-response assessment, or risk assessment purposes as the current test method recommended or required by that agency;
(3)the agency does not employ, recommend, or require testing for that class of chemical or for the recommended test endpoint; or
(4)the ICCVAM test recommendation is unacceptable for satisfactorily fulfilling the test needs for that particular agency and its respective congressional mandate.

Legislative History

Notes & Related Subsidiaries

Editorial Notes

Codification Section was enacted as part of the ICCVAM Authorization Act of 2000, and not as part of the Public Health Service Act which comprises this chapter.

Reference

Citations & Metadata

Citation

42 U.S.C. § 285l–4

Title 42, The Public Health and Welfare

Last Updated

Sep 22, 2026

Release point: 119-110